(VIANEWS) – ELIS (ELIS.PA), OKEA (OKEA.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 9.02% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €1.19.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 16.94. Meaning, the purchaser of the share is investing €16.94 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 4.14B for the twelve trailing months.
Yearly Top and Bottom Value
ELIS’s stock is valued at €20.16 at 01:20 EST, higher than its 52-week high of €19.37.
Moving Average
ELIS’s worth is way higher than its 50-day moving average of €17.28 and way above its 200-day moving average of €17.35.
Volume
Today’s last reported volume for ELIS is 101704 which is 61.73% below its average volume of 265777.
More news about ELIS.
2. OKEA (OKEA.OL)
50.3% sales growth and 32.98% return on equity
OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, OKEA has a trailing twelve months EPS of kr6.27.
PE Ratio
OKEA has a trailing twelve months price to earnings ratio of 3.7. Meaning, the purchaser of the share is investing kr3.7 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.98%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 1, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 17.01%.
More news about OKEA.
3. NAVAMEDIC (NAVA.OL)
20.7% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.2. Meaning, the purchaser of the share is investing kr32.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
Volume
Today’s last reported volume for NAVAMEDIC is 4015 which is 61.6% below its average volume of 10458.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr38.00 at 01:20 EST, way under its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.9%, now sitting on 502.65M for the twelve trailing months.
More news about NAVAMEDIC.
4. PARETO BANK (PARB.OL)
15.7% sales growth and 13.76% return on equity
Pareto Bank ASA provides various banking products and services in Norway. The company accepts corporate deposits. It also offers corporate financing; receivables financing; residential and commercial financing for land and property; ship financing, including corporate and project financing; and other private or housing loans. Pareto Bank ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PARETO BANK has a trailing twelve months EPS of kr7.75.
PE Ratio
PARETO BANK has a trailing twelve months price to earnings ratio of 7.14. Meaning, the purchaser of the share is investing kr7.14 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.76%.
Moving Average
PARETO BANK’s worth is higher than its 50-day moving average of kr53.51 and above its 200-day moving average of kr52.36.
Volume
Today’s last reported volume for PARETO BANK is 3613 which is 85.82% below its average volume of 25488.
More news about PARETO BANK.
5. ODFJELL TECHNOLOGY (OTL.OL)
12.4% sales growth and 34.07% return on equity
Odfjell Technology Ltd., a technology and engineering company, provides well, drilling, and engineering services in Norway, Europe, Asia, the United Kingdom, and internationally. The company operates through three segments: Well Services; Operations; and Projects & Engineering. The Well Services segment provides casing and tubular running services, including automated and conventional; drilling tool and tubular rental services; and specialist well intervention products and services for exploration wells and for production. The Operations segment engages in the production of drilling and well completion on client's rigs. This segment is also involved in the slot recovery, plug and abandonment, work-overs, and maintenance activities; and provision of platform drilling services on both fixed production platforms and on floating production platforms with subsea blowout preventers along with the management and performance of the services on leased Jack-up rigs. The Projects & Engineering segment offers engineering and integrity services, including design and engineering to building supervision; and project management and operational support for units in operation, newbuild projects, and SPS/RS recertification projects and yard stays. The company was founded in 1973 and is headquartered in Aberdeen, the United Kingdom.
Earnings Per Share
As for profitability, ODFJELL TECHNOLOGY has a trailing twelve months EPS of kr7.92.
PE Ratio
ODFJELL TECHNOLOGY has a trailing twelve months price to earnings ratio of 6.94. Meaning, the purchaser of the share is investing kr6.94 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.07%.
Yearly Top and Bottom Value
ODFJELL TECHNOLOGY’s stock is valued at kr55.00 at 01:20 EST, way below its 52-week high of kr62.90 and way higher than its 52-week low of kr36.01.
Moving Average
ODFJELL TECHNOLOGY’s worth is above its 50-day moving average of kr54.52 and above its 200-day moving average of kr51.35.
Volume
Today’s last reported volume for ODFJELL TECHNOLOGY is 66903 which is 23.35% below its average volume of 87287.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 13, 2023, the estimated forward annual dividend rate is 2.53 and the estimated forward annual dividend yield is 4.6%.
More news about ODFJELL TECHNOLOGY.
6. SATS (SATS.OL)
10.1% sales growth and 3.89% return on equity
Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SATS has a trailing twelve months EPS of kr0.17.
PE Ratio
SATS has a trailing twelve months price to earnings ratio of 107.88. Meaning, the purchaser of the share is investing kr107.88 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
More news about SATS.
